Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes-Reference-Cited by-同舟云学术

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes

Published:2018-10-30 Issue:1 Volume:6 Page:33-45
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Bhargava Pavan¹^ORCID,Fitzgerald Kathryn C.¹,Venkata Swarajya L. V.¹,Smith Matthew D.¹,Kornberg Michael D.¹,Mowry Ellen M.¹,Haughey Norman J.¹,Calabresi Peter A.¹

Affiliation:

1. Department of Neurology; Johns Hopkins University School of Medicine; Baltimore Maryland

Funder

Race to Erase MS

Biogen

NARCOMS

National Multiple Sclerosis Society

American Academy of Neurology

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acn3.676/fullpdf

Reference44 articles.

1. Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis;Oh;CNS Drugs,2013

2. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway;Linker;Brain,2011

3. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2;Schulze-Topphoff;Proc Natl Acad Sci U S A,2016

4. Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE;Chen;J Clin Invest,2014

5. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity;Kornberg;Science,2018

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocrelizumab alters the circulating metabolome in people with relapsing–remitting multiple sclerosis;Annals of Clinical and Translational Neurology;2024-08-26

2. Moderate-term dimethyl fumarate treatment reduces pathology of dystrophic skeletal and cardiac muscle in a mouse model;2024-07-17

3. Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases;Redox Biology;2024-04

4. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells;Cellular and Molecular Life Sciences;2024-02-03

5. Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course;Cell Host & Microbe;2024-02